Ignite Creation Date:
2024-05-06 @ 1:18 PM
Last Modification Date:
2024-10-26 @ 1:12 PM
Study NCT ID:
NCT03988114
Status:
WITHDRAWN
Last Update Posted:
2019-09-06
First Post:
2019-06-12
Brief Title:
A Study of Abemaciclib LY2835219 in Participants With HR HER2- Advanced Breast Cancer
Sponsor:
Eli Lilly and Company
Organization:
Eli Lilly and Company
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-16
Start Date Type:
ESTIMATED
Primary Completion Date:
2022-03-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-03-23
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-12
First Submit QC Date:
June 12 2019
Study First Post Date:
2019-06-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-09-04
Last Update Post Date:
2019-09-06
Last Update Post Date Type:
ACTUAL